2010
DOI: 10.1007/s00120-010-2264-1
|View full text |Cite
|
Sign up to set email alerts
|

Konservative Therapie der postoperativen Harninkontinenz des Mannes

Abstract: Urinary incontinence in men most commonly occurs after radical prostatectomy. Of these patients, 3-23% remain incontinent a year after prostatectomy. Data on conservative therapy for postoperative incontinence is contradictory. Nonetheless, conservative treatment strategies must generally be attempted before any operative technique. Early pelvic floor muscle training with or without biofeedback therapy and duloxetine seem to have a positive effect on continence. Further randomised controlled studies are necess… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2012
2012
2013
2013

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 40 publications
(79 reference statements)
0
1
0
1
Order By: Relevance
“…Some authors consider ExMI an interesting option for stress incontinence (Bortolami, 2009), but the effects of this treatment remain overall unclear (Campbell et al, 2012) due to the difficulties in comparing studies with different design and levels of methodological quality. This treatment has also been studied in women (Groenendijk et al, 2008) and children (Kang et al, 2007), but there is no clear evidence regarding its efficacy in postprostatectomy urinary incontinence (Campbell et al, 2012;Nyarangi-Dix et al, 2010).…”
Section: Rationale For This Studymentioning
confidence: 99%
“…Some authors consider ExMI an interesting option for stress incontinence (Bortolami, 2009), but the effects of this treatment remain overall unclear (Campbell et al, 2012) due to the difficulties in comparing studies with different design and levels of methodological quality. This treatment has also been studied in women (Groenendijk et al, 2008) and children (Kang et al, 2007), but there is no clear evidence regarding its efficacy in postprostatectomy urinary incontinence (Campbell et al, 2012;Nyarangi-Dix et al, 2010).…”
Section: Rationale For This Studymentioning
confidence: 99%
“…Das Präparat (Duloxetin) ist nur für Frauen zugelassen und kann bei Männern im Off-Label-Gebrauch angewandt werden. Studien zeigen aber, dass Duloxetin auch beim Mann gerade nach radikaler Prostatektomie wirksam ist (Nyarangi-Dix et al 2010;Schlenker et al 2006). Aufgrund der vor allem zu Beginn der Therapie vorkommenden Nebenwirkungen sollte eine einschleichende Dosierung erfolgen.…”
Section: IIunclassified